Test validation and availability
IndiTreat® is ready for your patients today
IndiTreat® Colorectal Cancer Sensitivity Test is a CE IVD validated test available throughout the EU and the UK.
IndiTreat® tests are performed at 2cureX laboratories in Europe. We can perform tests on your patients and can compare to results from reference patients.
Drug sensitivity testing on patient-derived 3D microtumors can provide vital information for every individual patient, and improve the likelihood of success of cancer treatment. IndiTreat® is a useful complement to the advances achieved in individual patient genomic characterization of tumors.
Improving the likelihood of success of cancer treatment
2cureX, pioneers in the use of 3D microtumors in cancer therapy, are empowering oncologists to select treatments more efficiently and thereby improve treatment outcomes.
Please contact 2cureX for more information
September 15, 2021 at 15:00 (CET)
Interview with CEO Fernando Andreu (organized by Mangold) Open participation. Details provided later.
September 23, 2021
CSO Ole Thastrup will speak at the conference “Week of Health and Innovation 2021” in Odense, Denmark
September 28, 2021
Redeye Medtech & Diagnostics Investor meeting
September 29, 2021
Mangold Investor Lunch